pharmaphorum
OCTOBER 28, 2021
26, 2021 — Cerner Corporation (NASDAQ: CERN), a global healthcare technology company, announces the launch of a new operating unit, Cerner Enviza SM , that offers data-driven solutions and research services to help bring clarity to multi-dimensional data through real-world evidence and insights. president and CEO, Cerner.
pharmaphorum
AUGUST 7, 2020
Health technology firms Cerner and LRVHealth have invested $6 million in Xealth to scale up its business offering digital health tools to patients and clinicians. As a result new methods have been created to inform care decisions and keep care teams and patients connected.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
APRIL 11, 2023
Oracle company Cerner Enviza and John Snow Labs have collaborated with the US Food and Drug Administration (FDA) for the development of artificial intelligence (AI) tools for drug safety and real-world evidence studies. Together, Cerner Enviza and John Snow Labs have all the right expertise, data and technology to make it happen.”
pharmaphorum
DECEMBER 20, 2021
In a year already marked by big-ticket deals in the digital health arena, there may be even more to come, as reports circulate of a $30 billion offer looming for electronic health record (EHR) specialist Cerner by Oracle. The post Is Oracle about to buy electronic health record provider Cerner? billion this year. appeared first on.
pharmaphorum
AUGUST 3, 2022
It’s been more than two decades since the ground-breaking potential of using electronic health records (EHR) to inform clinical research was first mooted. Collaborative projects, such as the Cerner Learning Health Network, which all three companies are involved, offer the support willing sites and healthcare systems need to take part. “It
Omnicell
JANUARY 10, 2023
When Omnicell partnered with Oracle Cerner for interoperability between the EHR and the XT Automated Dispensing System , the result was improved waste compliance, near 100 percent visibility of potential transaction discrepancies, and time savings for nursing and pharmacy.
Hospital Pharmacy Europe
JANUARY 4, 2023
They made use of information held in the Cerner Real-World Data , which is large US database that receives input from 122 centres across the US. In the present study, the US researchers focused on the identification of the persistent symptoms that could be used to define post COVID-19 condition.
Expert insights. Personalized for you.
98 
Let's personalize your content